|
1
|
Sham JS, Wei WI, Zong YS, Choy D, Guo YQ,
Luo Y, Lin ZX and Ng MH: Detection of subclinical nasopharyngeal
carcinoma by fibreoptic endoscopy and multiple biopsy. Lancet.
335:371–374. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chang ET and Adami HO: The enigmatic
epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol
Biomarkers Prev. 15:1765–1777. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shin HR, Curado MP, Ferlay J, Heanue M,
Edwards B and Storm H: Comparability and Quality of DataCancer
Incidence in Five Continents. Parkin DM and Muir CS: IARC Sci Publ;
pp. 45–173. 1992
|
|
4
|
Nielsen NH, Mikkelsen F and Hansen JP:
Nasopharyngeal cancer in Greenland. The incidence in an Arctic
Eskimo population. Acta Pathol Microbiol Scand A. 85:850–858.
1977.PubMed/NCBI
|
|
5
|
Yu MC and Yuan JM: Epidemiology of
nasopharyngeal carcinoma. Semin Cancer Biol. 12:421–429. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gu AD, Mo HY, Bei JX, Xie YB, Chen LZ,
Feng QS, Kang T and Zeng YX: Evaluation of antibodies against
different Epstein-Barr virus nuclear antigen 1 peptides in
diagnosis of nasopharyngeal carcinoma. Clin Vaccine Immunol.
16:592–593. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chiesa F and De Paoli F: Distant
metastases from nasopharyngeal cancer. ORL J Otorhinolaryngol Relat
Spec. 63:214–216. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Korndörfer IP, Brueckner F and Skerra A:
The crystal structure of the human (S100A8/S100A9)2 heterotetramer,
calprotectin, illustrates how conformational changes of interacting
alpha-helices can determine specific association of two EF-hand
proteins. J Mol Biol. 370:887–898. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ott HW, Lindner H, Sarg B, Mueller-Holzner
E, Abendstein B, Bergant A, Fessler S, Schwaerzler P, Zeimet A,
Marth C, et al: Calgranulins in cystic fluid and serum from
patients with ovarian carcinomas. Cancer Res. 63:7507–7514.
2003.PubMed/NCBI
|
|
10
|
Donato R: S100: A multigenic family of
calcium-modulated proteins of the EF-hand type with intracellular
and extracellular functional roles. Int J Biochem Cell Biol.
33:637–668. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kong JP, Ding F, Zhou CN, Wang XQ, Miao
XP, Wu M and Liu ZH: Loss of myeloid-related proteins 8 and
myeloid-related proteins 14 expression in human esophageal squamous
cell carcinoma correlates with poor differentiation. World J
Gastroenterol. 10:1093–1097. 2004.PubMed/NCBI
|
|
12
|
Gebhardt C, Németh J, Angel P and Hess J:
S100A8 and S100A9 in inflammation and cancer. Biochem Pharmacol.
72:1622–1631. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Salama I, Malone PS, Mihaimeed F and Jones
JL: A review of the S100 proteins in cancer. Eur J Surg Oncol.
34:357–364. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim HJ, Kang HJ, Lee H, Lee ST, Yu MH, Kim
H and Lee C: Identification of S100A8 and S100A9 as serological
markers for colorectal cancer. J Proteome Res. 8:1368–1379. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hermani A, Hess J, De Servi B, et al:
Calcium-binding proteins S100A8 and S100A9 as novel diagnostic
markers in human prostate cancer. Clin Cancer Res. 11:5146–5152.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Saha A, Lee YC, Zhang Z, Chandra G, Su SB
and Mukherjee AB: Lack of an endogenous anti-inflammatory protein
in mice enhances colonization of B16F10 melanoma cells in the
lungs. J Biol Chem. 285:10822–10831. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yong HY and Moon A: Roles of
calcium-binding proteins, S100A8 and S100A9, in invasive phenotype
of human gastric cancer cells. Arch Pharm Res. 30:75–81. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Han RR, Huang YJ, Chen L, Xiao XL, Yi X,
Cai HW and Wu YH: Determination of S100A8 and S100A9 protein in
plasma of nasopharyngeal carcinoma patients and its clinical
significance. Chin J Clin Lab Sci. 32:252–254. 2014.[(In
Chinese)].
|
|
19
|
Hermani A, De Servi B, Medunjanin S,
Tessier PA and Mayer D: S100A8 and S100A9 activate MAP kinase and
NF-kappaB signaling pathways and trigger translocation of RAGE in
human prostate cancer cells. Exp Cell Res. 312:184–197. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hiratsuka S, Watanabe A, Aburatani H and
Maru Y: Tumour-mediated upregulation of chemoattractants and
recruitment of myeloid cells predetermines lung metastasis. Nat
Cell Biol. 8:1369–1375. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kwon CH, Moon HJ, Park HJ, Choi JH and
Park Y: S100A8 and S100A9 promotes invasion and migration through
p38 mitogen-activated protein kinase-dependent NF-κB activation in
gastric cancer cells. Mol Cells. 35:226–234. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Roy R, Yang J and Moses MA: Matrix
metalloproteinases as novel biomarkers and potential therapeutic
targets in human cancer. J Clin Oncol. 27:5287–5297. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Moon A, Yong HY, Song JI, Cukovic D,
Salagrama S, Kaplan D, Putt D, Kim H, Dombkowski A and Kim HR:
Global gene expression profiling unveils S100A8/A9 as candidate
markers in H-ras-mediated human breast epithelial cell invasion.
Mol Cancer Res. 6:1544–1553. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Duan L, Wu R, Ye L, Wang H, Yang X, Zhang
Y, Chen X, Zuo G, Zhang Y, Weng Y, et al: S100A8 and S100A9 are
associated with colorectal carcinoma progression and contribute to
colorectal carcinoma cell survival and migration via Wnt/β-catenin
pathway. PLoS One. 8:e620922013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ichikawa M, Williams R, Wang L, Vogl T and
Srikrishna G: S100A8/A9 activate key genes and pathways in colon
tumor progression. Mol Cancer Res. 9:133–148. 2011. View Article : Google Scholar : PubMed/NCBI
|
